Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment ...
Glenmark Pharmaceuticals rose 1.13% to Rs 2,234.90 after its subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial in the United States.
The company's arm Glenmark Pharmaceuticals Inc, USA has launched Olanzapine for injection of strength 10 mg/vial, single-dose vial, Glenmark said in a regulatory filing ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of symptomatic COVID-19 versus placebo, at three months, from a ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval ...
News, recaps, highlights and winners from the Tokyo Paralympic Games on the night of Thursday, August 26 and morning of ...
Nerve blocks—local anesthetic injections that block pain signals—are a valuable opioid-sparing technique for controlling pain ...
Verywell Health on MSN
What you need to know about COVID arm rash
Medically reviewed by Renee Nilan, MD Key Takeaways COVID arm rash is a mild reaction that usually appears a week after the ...
The FDA has approved a subcutaneous version of isatuximab (Sarclisa Escena, Sanofi-Aventis) for several multiple myeloma (MM) ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results